News Does the Novavax delay augur a COVID vaccine policy change? Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
Views & Analysis Not just COVID-19 vaccines: 5 things that cause blood clots Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
